Having trouble accessing articles? Reset your cache.

Onyx delays carfilzomib submission

Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) will delay an NDA submission for multiple myeloma

Read the full 122 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE